Antioxidant and hepatoprotective effects of Korean ginseng extract GS-KG9 in a D-galactosamine-induced liver damage animal model
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
BACKGROUND/OBJECTIVES: This study was designed to investigate the improvement effect of white ginseng extract (GS-KG9) on D-galactosamine (Ga1N)-induced oxidative stress and liver injury. SUBJECTS/METHODS: Sixty Sprague-Dawley rats were divided into 6 groups. Rats were orally administrated with GS-KG9 (300, 500, or 700 mg/kg) or silymarin (25 mg/kg) for 2 weeks. The rats of the GS-KG9- and silymarin-treated groups and a control group were then intraperitoneally injected Ga1N at a concentration of 650 mg/kg for 4 days. To investigate the protective effect of GS-KG9 against GalN-induced liver injury, blood liver function indicators, anti-oxidative stress indicators, and histopathological features were analyzed. RESULTS: Serum biochemical analysis indicated that GS-KG9 ameliorated the elevation of aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), and lactate dehydrogenase (LDH) in GalN-treated rats. The hepatoprotective effects of GS-KG9 involved enhancing components of the hepatic antioxidant defense system, including glutathione, glutathione peroxidase (GPx), superoxide dismutase (SOD), and catalase (CAT). In addition, GS-KG9 treatment inhibited reactive oxygen species (ROS) production induced by GalN treatment in hepatocytes and significantly increased the expression levels of nuclear factor erythroid-2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1) proteins, which are antioxidant proteins. In particular, by histological analyses bases on hematoxylin and eosin, Masson's trichrome, α-smooth muscle actin, and transforming growth factor-β1 staining, we determined that the administration of 500 mg/kg GS-KG9 inhibited hepatic inflammation and fibrosis due to the excessive accumulation of collagen. CONCLUSIONS: These findings demonstrate that GS-KG9 improves GalN-induced liver inflammation, necrosis, and fibrosis by attenuating oxidative stress. Therefore, GS-KG9 may be considered a useful candidate in the development of a natural preventive agent against liver injury.
Abstract
BACKGROUND/OBJECTIVES: This study was designed to investigate the improvement effect of white ginseng extract (GS-KG9) on D-galactosamine (Ga1N)-induced oxidative stress and liver injury. SUBJECTS/METHODS: Sixty Sprague-Dawley rats were divided into 6 groups. Rats were orally administrated with GS-KG9 (300, 500, or 700 mg/kg) or silymarin (25 mg/kg) for 2 weeks. The rats of the GS-KG9- and silymarin-treated groups and a control group were then intraperitoneally injected Ga1N at a concentration of 650 mg/kg for 4 days. To investigate the protective effect of GS-KG9 against GalN-induced liver injury, blood liver function indicators, anti-oxidative stress indicators, and histopathological features were analyzed. RESULTS: Serum biochemical analysis indicated that GS-KG9 ameliorated the elevation of aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), and lactate dehydrogenase (LDH) in GalN-treated rats. The hepatoprotective effects of GS-KG9 involved enhancing components of the hepatic antioxidant defense system, including glutathione, glutathione peroxidase (GPx), superoxide dismutase (SOD), and catalase (CAT). In addition, GS-KG9 treatment inhibited reactive oxygen species (ROS) production induced by GalN treatment in hepatocytes and significantly increased the expression levels of nuclear factor erythroid-2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1) proteins, which are antioxidant proteins. In particular, by histological analyses bases on hematoxylin and eosin, Masson's trichrome, α-smooth muscle actin, and transforming growth factor-β1 staining, we determined that the administration of 500 mg/kg GS-KG9 inhibited hepatic inflammation and fibrosis due to the excessive accumulation of collagen. CONCLUSIONS: These findings demonstrate that GS-KG9 improves GalN-induced liver inflammation, necrosis, and fibrosis by attenuating oxidative stress. Therefore, GS-KG9 may be considered a useful candidate in the development of a natural preventive agent against liver injury.
참고문헌 (34)
- Jaeschke H, "Mechanisms of hepatotoxicity", Toxicol Sci, 65, pp.166~176 (2002)
- Patel T, "Dysregulation of apoptosis as a mechanism of liver disease : an overview", Semin Liver Dis, 18, pp.105~114 (1998)
- Li S, "The role of oxidative stress and antioxidants in liver diseases", Int J Mol Sci, 16, pp.26087~26124 (2015)
- Aubé C, "Liver fibrosis, cirrhosis, and cirrhosis-related nodules : Imaging diagnosis and surveillance", Diagn Interv Imaging, 98, pp.455~468 (2017)
- Hong IH, "JNK1 and JNK2 regulate α-SMA in hepatic stellate cells during CCl4-induced fibrosis in the rat liver", Pathol Int, 63, pp.483~491 (2013)
- Keppler D, "Studies on the mechanism of galactosamine-1-phosphate and its inhibition of UDPglucose pyrophosphorylase", Eur J Biochem, 10, pp.219~225 (1969)
- Pushpavalli G, "Effect of chrysin on hepatoprotective and antioxidant status in D-galactosamine-induced hepatitis in rats", Eur J Pharmacol, 631, pp.36~41 (2010)
- Choi KT, "Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C A Meyer", Acta Pharmacol Sin, 29, pp.1109~1118 (2008)
- Shin MS, "Stimulation of innate immune function by Panax ginseng after heat processing", J Agric Food Chem, 66, pp.4652~4659 (2018)
- Choi JG, "White ginseng protects mouse hippocampal cells against amyloid-beta oligomer toxicity", Phytother Res, 31, pp.497~506 (2017)
- Liu Z, "The effects of dynamic changes of malonyl ginsenosides on evaluation and quality control of Panax ginseng C.A. Meyer", J Pharm Biomed Anal, 64-65, pp.56~63 (2012)
- Du XW, "Changes in neutral and malonyl ginsenosides in American ginseng(Panax quinquefolium)during drying, storage and ethanolic extraction", Food Chem, 86, pp.155~159 (2004)
- Liu Z, "Antidiabetic effects of malonyl ginsenosides from Panax ginseng on type 2 diabetic rats induced by high-fat diet and streptozotocin", J Ethnopharmacol, 145, pp.233~240 (2013)
- 오명환, "백삼 및 홍삼의 이화학적 특성 및 말로닐 진세노사이드 함량 비교", 생약학회지, 47(1), pp.84~91 (2016), 한국생약학회
- Kuan-Hung Lu, "Ginseng essence, a medicinal and edible herbal formulation, ameliorates carbon tetrachloride-induced oxidative stress and liver injury in rats", Journal of Ginseng Research, 41(3), pp.316~325 (2017), 고려인삼학회[DOI]
- 김명환, "Antioxidant and hepatoprotective effects of fermented red ginseng against high fat diet-induced hyperlipidemia in rats", Laboratory Animal Research, 32(4), pp.217~223 (2016), 한국실험동물학회
- Wang W, "Sesquiterpenoids from the root of Panax ginseng protect CCl4-induced acute liver injury by anti-inflammatory and anti-oxidative capabilities in mice", Biomed Pharmacother, 102, pp.412~419 (2018)
- Niranjana Murthy H, "Hepatoprotective activity of ginsenosides from Panax ginseng adventitious roots against carbon tetrachloride treated hepatic injury in rats", J Ethnopharmacol, 158(Pt A), pp.442~446 (2014)
- McGill MR, "The past and present of serum aminotransferases and the future of liver injury biomarkers", EXCLI J, 15, pp.817~828 (2016)
- Saraç F, "Causes of high bone alkaline phosphatase", Biotechnol Biotechnol Equip, 21, pp.194~197 (2007)
- Chaudhary A, "Lactate dehydrogenase as an indicator of liver diseases", J Adv Med Dent Sci Res, 3, pp.S20~S22 (2015)
- Ighodaro OM, "First line defence antioxidants-superoxide dismutase(SOD), catalase(CAT)and glutathione peroxidase(GPX) : Their fundamental role in the entire antioxidant defence grid", Alexandria J Med, 54, pp.287~293 (2018)
- Hu HL, "Changes in free radicals, trace elements, and neurophysiological function in rats with liver damage induced by D-galactosamine", Biol Trace Elem Res, 34, pp.19~25 (1992)
- Shanmugam Parthasarathi, "Anti-oxidant and Hepatoprotective Effect of White Ginsengs in H2O2-Treated HepG2 Cells", Natural Product Sciences, 21(3), pp.210~218 (2015), 한국생약학회
- Kemelo MK, "Comparative effects of Quercetin and SRT1720 against D-galactosamine", lipopolysaccharide-induced hepatotoxicity in rats : biochemical and molecular biological investigations, 2016, pp.20, 363~371
- Choi JW, "Pyropia yezoensis glycoprotein regulates antioxidant status and prevents hepatotoxicity in a rat model of D-galactosamine", lipopolysaccharide-induced acute liver failure, 2016, pp.13, 3110~3114
- Takahashi T, "Heme oxygenase-1 : a novel therapeutic target in oxidative tissue injuries", Curr Med Chem, 11, pp.1545~1561 (2004)
- Tian Y, "The protective effects of Shikonin on lipopolysaccharide", D-galactosamine-induced acute liver injury via inhibiting MAPK and NF-κB and activating Nrf2, RSC Advances, pp.2017, 7[DOI]
- Ma Q, "Role of Nrf2 in oxidative stress and toxicity", Annu Rev Pharmacol Toxicol, 53, pp.401~426 (2013)
- Guyot C, "Hepatic fibrosis and cirrhosis : the(myo)fibroblastic cell subpopulations involved", Int J Biochem Cell Biol, 38, pp.135~151 (2006)
- Bataller R, "Liver fibrosis", J Clin Invest, 115, pp.209~218 (2005)
- Tomanovic NR, "Activated liver stellate cells in chronic viral C hepatitis : histopathological and immunohistochemical study", J Gastrointestin Liver Dis, 18, pp.163~167 (2009)
- Liu RM, "Reciprocal regulation of TGF-β and reactive oxygen species : A perverse cycle for fibrosis", Redox Biol, 6, pp.565~577 (2015)
- Meng XM, "TGF-β : the master regulator of fibrosis", Nat Rev Nephrol, 12, pp.325~338 (2016)